Article
Roundup: Bluetooth Medical Devices Cleared by FDA in 2023
One of the reasons VGBio is one of Orthogonal’s favorite clients is because they show how four of the most powerful technology trends affecting healthcare (body area sensor networks, smartphones, cloud computing and big data/predictive analytics) can be used together to reduce costs and improve outcomes. VGBio technology enables the daily monitoring of patients with chronic diseases and provides early notification to clinicians of a negative change.
According to Dr. Abdulfattah Saidi, Heart Failure/Transplant Research Fellow at the George V. Whalen VA Medical Center, “When we admit patients, and we take care of them, and then send them home, there’s a 20% chance that they will come back to the hospital within 30 days of discharge.”
Dr. Jose Nativi-Nicolau, Heart Failure/Transplant Cardiology at the George V. Whalen VA Medical Center, adds that “The benefit to the VA is to reduce readmissions and improve the care from hospital to home, and from home to clinic.”
Systems like VGBio are part of a growing trend of companies that combine bio sensors, mobile technology and bioinformatics to transform the management of chronic diseases from a reactive to a proactive care delivery model. Other examples include:
Are you working on a similar project?
Do you have questions related to connecting sensors to mobile devices?
Send us a note!
Learn about our process here.
Related Posts
Article
Roundup: Bluetooth Medical Devices Cleared by FDA in 2023
Article
EU Commission’s MDR Fast Track Plans: Good but Not Enough
Article
NIST-Proposed Cybersecurity Guidance & Its Potential Impact to MedTech
Article
SaMD Watering Holes: Job Boards & Regional Organizations